Bioretec Oy announced an equity round of funding for gross proceeds of 749,999 on January 3, 2013. The securities will be issued pursuant to Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 EUR | +0.69% | -0.34% | +20.83% |
06-28 | Bioretec Flags Delay in Receipt of European CE Mark for Trauma Screw | MT |
06-19 | Bioretec Ltd. Reports Successful Clinical Outcomes from U.S. Controlled Launch of RemeOs Trauma Screw | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.83% | 64.49M | |
+75.69% | 12.57B | |
-19.21% | 7.88B | |
-7.03% | 5.8B | |
+10.32% | 5.26B | |
-16.50% | 4.84B | |
-12.06% | 4.37B | |
+17.06% | 4.19B | |
-9.70% | 3.41B | |
+28.00% | 2.06B |
- Stock Market
- Equities
- BRETEC Stock
- News Bioretec Oy
- Bioretec Oy announced that it expects to receive €0.75 million in funding.